summary
Introduced
02/28/2020
02/28/2020
In Committee
02/28/2020
02/28/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
To expand the tropical disease product priority review voucher program to encourage treatments for coronavirus. This bill expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.
AI Summary
This bill expands the tropical disease priority review voucher program to include COVID-19, a respiratory disease caused by a novel coronavirus. This provides manufacturers with incentives to develop a vaccine for COVID-19 by allowing them to receive a priority review voucher upon approval of their vaccine, which can be used to expedite the review of a future drug application.
Committee Categories
Business and Industry
Sponsors (9)
Hakeem Jeffries (D)*,
Tony Cárdenas (D),
Yvette Clarke (D),
Steve Cohen (D),
Josh Harder (D),
Jahana Hayes (D),
Jaime Herrera Beutler (R),
Peter King (R),
David Trone (D),
Last Action
Referred to the House Committee on Energy and Commerce. (on 02/28/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/6019/all-info |
| BillText | https://www.congress.gov/116/bills/hr6019/BILLS-116hr6019ih.pdf |
| Bill | https://www.congress.gov/116/bills/hr6019/BILLS-116hr6019ih.pdf.pdf |
Loading...